Literature DB >> 33687481

[Successful treatment of generalized pustular psoriasis with certolizumab].

Hannah Post1, Nina Magnolo1, Markus Böhm2.   

Abstract

Generalized pustular psoriasis is a rare, often relapsing and usually severe inflammatory skin disease with concomitant systemic symptoms in many cases. The disease is in part due to mutations in the gene of the interleukin-36 receptor antagonist (IL36RN) explaining the autoinflammatory nature of this condition. Here, we report on a 39-year-old pregnant woman who stopped her medication with secukinumab due to her pregnancy. Subsequently, she suffered from severe exacerbation of her disease and was admitted to our hospital. The patient had a known mutation in the IL36RN (Ser113Leu) gene. At the 33rd week of her pregnancy therapy with certolizumab was initiated and resulted in a rapid remission within a few weeks. After the patient gave birth, remission could be maintained under the given therapy with this biologic.

Entities:  

Keywords:  Biologicals; Inflammatory skin diseases; Interleukin-36 receptor antagonist; Lactation period; Pregnancy

Year:  2021        PMID: 33687481     DOI: 10.1007/s00105-021-04784-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  1 in total

1.  Generalized pustular psoriasis in pregnancy, successfully treated with certolizumab pegol.

Authors:  Yoko Mizutani; Yuki H Mizutani; Kanako Matsuyama; Miho Kawamura; Asami Fujii; En Shu; Hidenori Ohnishi; Mariko Seishima
Journal:  J Dermatol       Date:  2020-05-04       Impact factor: 4.005

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.